Breaking News: Expert Perspective on Venclexta (venetoclax) Approval
The U.S. Food and Drug Administration (FDA) has approved a new drug Venclexta (venetoclax) for use in CLL patients with the 17p deletion. Andrew Schorr interviewed CLL expert Dr. Thomas Kipps to get h...
Author: patientpower
Added: 04/13/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Food and Drug Administration (FDA)